StockData
SpyGlass Pharma, Inc. logo

SpyGlass Pharma, Inc. (SGP) stock

SGPNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$29.68−1.75 (-5.58%)

Close on Nov 18, 2026Market cap $992.74MP/E –Yield –

SpyGlass Pharma cash

Cash and short-term investments held at the end of each period.

SpyGlass Pharma's cash was $223.14M at Jun 30, 2026. For fiscal 2025 it was $96.36M, up 492.3% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$96.36M+492.3%
FY2024Dec 31, 2024$16.27M+2.6%
FY2023Dec 31, 2023$15.85M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$223.14M+284.7%
Q1 FY2026Mar 31, 2026$238.90M+1368.5%
Q4 FY2025Dec 31, 2025$96.36M+508.0%
Q2 FY2025Jun 30, 2025$127.24M–
Q1 FY2025Mar 31, 2025$58.00M–
Q4 FY2024Dec 31, 2024$16.27M–
Q4 FY2023Dec 31, 2023$15.85M–

More SpyGlass Pharma figures

See a number that looks wrong?